Concepedia

Publication | Closed Access

GPC3 DNA vaccine elicits potent cellular antitumor immunity against HCC in mice.

20

Citations

0

References

2014

Year

Shaoqiang Li, Jie Lin, Chao-Ying Qi, Shunjun Fu, Weikai Xiao, Baogang Peng, Li‐Jian Liang
PubMed

Abstract

This study demonstrated the first time that the GPC3 DNA vaccine could elicit specific and effective cellular antitumor immunity against GPC3 HCC. This may provide an alternative option for immunotherapy of HCC.